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Abstract: Infertility as a social and psychological problem among middle east natives. 
Among them, Transvaginal ultrasound (TVU) and hormonal tests have been selected to 
evaluate infertility in this study. The objective was to assess the infertility factors and their 
relative impact in pregnancy and to deduce the equation to predict infertility. Methods: a 
retrospective data (morphometric pathologies of uterus and ovaries using TVU and 
laboratory hormones (FSH, LH)) have been collected from clinics for 180 women of 
reproductive age (15-49 years) in Sudan.  The data analyzed by SPSS. The results showed 
that there were 120 (66.7%) infertile and 60 (33.3%) fertile ladies based on the marriage 
date. The common ovarian causes of infertility were the polycystic ovary (PCOs) 23.3%, 
simple cyst 6.1%, hemorrhagic cyst, 4.4%, and uterus causes: 6.7% intramural fibroma, 6.1% 
retroverted uterus, 2.8% submural fibroma, 2.2 polyps. The general accuracy of Stepwise 
Linear Discriminant Analysis (SLDA) was 78.9%, for infertile was 70.8% and for fertile 95%. 
Larger ovarian width indicates significance (p < 0.05) infertility and FSH level low 
among infertile ladies, but LH is less dependent on discrimination.  
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Infertility denotes a failure to conceive within 
one or more years of regular unprotected coitus [1]. It 
has been one of most social and psychological problems 
such as stress and depression [2] for both genders, 
especially among Muslims and or middle east natives; 
and more over it limits the existence of mankind over 
the earth. Female Infertility factors represent 20% to 
70%, and males represent 2.5% to 12%. Infertility has 
been recorded at the highest rate in Africa and 
Central/Eastern Europe. And based on a variety of 
sources, rates of male infertility in North America, 
Australia, and Central and Eastern Europe varied from 
4.5-6%, 9%, and 8-12%, respectively [3]. The common 
induction factors for infertility have been highlighted 
by many scholars; [4, 9], that classified to (i) Ovarian 
factors; that include Polycystic Ovaries (PCO) and (ii) 
the common risk factors that include: reproductive 
(infertility, pregnancy-related risks), metabolic (obesity, 
insulin resistance (IR), gestational and type II diabetes 
(DM2) and cardiovascular risk factors) and (iii) 
psychological features (anxiety and depression, 
impaired quality of life, body image and eating 
disorders. In addition to (iv) chronic pelvic 
inflammatory disease, fibroids, anatomical problems, 
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endometrial/cervical polyp, free fluid in 
pelvic/abdominal cavity, endometritis, endometriosis, 
adenomyosis, chocolate cyst, tubo-ovarian mass, 
intrauterine and intrapelvic adhesions, septate uterus 
as well as pelvic abscess [4].  
The hormonal indexes related to infertilities have 
been highlighted by Williams [5], as the value of serum 
progesterone of > 30 nmol/liter is considered proof of 
adequate ovulation, although the WHO uses 18 
nmol/liter to confirm ovulation. Such test done on day 
2–4 of the cycle (if there is one), which identify four 
essential causes of ovulatory failure, such as: 
Normogonadotrophic anovulation, 
Hyperprolactinemia,  
Hypogonadotropic hypogonadism, and 
Hypergonadotropic hypogonadism.  
Regarding Follicular Stimulating Hormone 
(FSH); values are checked on day 2 to day 4 with a 
cutoff point of 12 IU/liter and should be not < 5 
mIU/ml; as the lower limit could be induced by 
hypogonadotrophic hypogonadism, which is usually a 
result of primary hypothalamic or pituitary failure in 
addition to excessive stress/exercise, malnutrition, or 
low weight. Hypergonadotrophic hypogonadism is 
defined by raised FSH concentrations (> 20 mIU/ml) 
and indicates ovarian failure. The increment of FSH 
above > 50 IU/ml is considered as a diagnostic index 
for ovarian failure; however, most patients with 
oligomenorrhoea or amenorrhoea will have normal 
gonadotrophins as part of the polycystic ovarian 
syndrome (PCOS).  
The normal Prolactin hormone (PH) range is 
600– 800 mIU/ml, as estrogen is normal [6]. Hence the 
increment of PH could be ascribed to pregnancy, 
pituitary prolactinoma, stalk compression by 
hypothalamic or pituitary tumors, thyroid failure, 
PCOS, psychotherapeutic medication, or other 
pathologies as mentioned by Illions [7]. To reveal and 
diagnose infertility among female; there have been 
several methods, including normal menstrual cycle, 
sufficient normal level of hormones, ovulation, 
hysterosalpingography (less common), A laparoscopy, 
A pelvic ultrasound, and genetic testing may be 
necessary to detect a genetic origin for infertility [8].  
Ultrasound is accepted as an essential imaging 
modality for evaluating and monitoring the 
reproductive system for diagnosis and screening 
purposes and follow-up of the normal stimulated cycle. 
More than any other new method, ultrasound has 
made significant improvements in female infertility's 
modern management, especially in predicting 
ovulation and detection of certain ovulatory disorders 
[9].  
Sonography has a vital role in depicting follicular 
development in patients treated for infertility and 
receiving ovulation induction medication.  Although 
the follicle size can indirectly infer the maturity of the 
oocytes, the sonographic information can be couple 
with estradiol values to provide an accurate assessment 
of the presence or absence and a number of mature 
follicular. The anatomic information obtained with 
sonography concerning the size and development of 
maturing follicular can be used to distinguish 
physiologic from insufficient or abnormal cycles [10]. 
Relative to all mentioned above methods of 
investigations, endovaginally ultrasonography has 
been utilized more commonly recently due to 
numerous advantages such as: noninvasive, accuracy 
84.1%, sensitivity 68.2%, specificity 91.5%, positive 
predictive value 79%, and 86% negative predictive 
value [11]. 
Authors have considered the current study 
among Sudanese ladies for the common cases 
encountered in clinical centers. The essential aim is to 
assess the infertility factors and their relative impact in 
pregnancy depending on endovaginally 




This study was carried out as cross-sectional, 
descriptive, and direct analytical prospective data (Age, 
height, weight, echogenicity, texture, size, and level of 
female hormones) using an ultrasound system (Toshiba 
Xario XG SSA-680A) and laboratory hormonal test. The 
sample size was 180 patients referred to ultrasound 
clinics in Sudan from December 2017 to December 2018. 
For a transvaginal ultrasound exam, the women lie 
down on a table with her knees bent her feet may be 
held in stirrups. The probe was covered with a sterile 
condom, and a gel was then induced gently inside the 
vagina. The health care provider moves and kicking the 
probe around the area to prospect the relative 
anatomical and pathological information in the uterus, 
fallopian tubes, and ovaries. And with the 
enhancement of ultrasound caliber, the morphometric 
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parameters of visualized pathologies, womb and 










Book Antiqua 10pt, Space 1, Justify 
 
Method  
Book Antiqua 11pt Bold, Space 1, Justify 
Research design and method should be clearly defined.  
 
Figure 1: (a) Endometrial polyp, (b) Fibroid with cystic 
changes measured 3.7 × 3.6 cm, (c) Endometrial leiomyomata 
(28.6 mm) attached to the myometrium by a pedicle and (d) 
Endometrium fibroids with cystic changes measured 3.7 × 3.6 
cm. 
The hormonal test results have been obtained as 
retrospective data from the patients' files. And the data 
analyzed using Excel software and linear discriminant 
analysis stepwise method, then the results presented in 
the form of bars, tables in addition to t-test. 
 
Result and Discussion 
 
Figure: 2, shows the distribution of ovarian 
pathologies finding using TVU. From the total sample 
of 180 females, 120 (66.7%) ladies were considered 
infertile based on the marriage date. The ultrasound 
scan revealed that: out of 120 infertile ladies; there was 
30.6% have normal ovaries, 23.3% have Polycystic 
Ovarian Syndrome PCOs, 6.1% have Simple Cyst, 4.4% 
have Hemorrhagic Cyst, 1.1% have Endometrioma, and 
1.1% have Dermoid Cyst. While ultrasound scanning 
for the fertile rest of sample 60 (33.3%) ladies revealed 
that: the normal ladies represent 32.2%, and simple cyst 
1.1%. These findings represent the same viable 
infertility factors nominated by Hussain & Das [12]. 
PCOs have a high percentage (23.3%) among infertile 
ladies, as it could cause an increased amount of 
testosterone and LH and decrease uptake of glucose by 
muscle, fat, and liver cells, resulting in large amounts of 
insulin by the pancreas. Low follicular stimulating 
hormones (FSH) levels also hinder the production of 
eggs from the ovarian follicles and form fluid-filled 
ovarian cysts that eventually cover the whole ovaries 
and prevent conception [13]. 
 
 
Figure: 2 Shows the percentage distribution of ovarian 
ultrasound findings in respect to fertility status 
 
Parallel to these findings, ultrasound scanning of 
the uterus (Figure: 3) showed that: among the infertile 
ladies 120 (66.7%), there were 44.4% as normal uterus, 
1.7% as subserous fibroma, 7.6% intramural fibroma, 
2.8% sub-mural fibroma, 2.2% polyps, 0.6% bicornuate 
uterus, 1.1% adenomyosis and 6.1% retroverted uterus. 
While ultrasound scanning for the fertile rest of sample 
60 (33.3%) ladies revealed that: the normal ladies 
represent 31.1%, and subserous fibroma 0.6% and 1.7% 
have intramural fibroma. Relative to these findings; 
intramural fibroma (7.6%) and retroverted uterus 
(6.1%) attributed with the high incidence of infertilities 
as they cause distortion of the uterine cavity resulted in 
the decreased rates of clinical pregnancy, implantation, 
and ongoing pregnancy/live birth, as well as an 
increased rate of spontaneous miscarriage [14].  
 
 
Figure: 3, Shows the percentage distribution of ultrasound 
uterus findings in respect to fertility status 
 
To classify the female as fertile and infertile 
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as the most discriminant ones: FSH, LH, Rt ovary 
width, and Lt ovary length (Table: 1). The overall 
classification accuracy was 78.9%, for infertile was 
70.8% and 95% for the fertile one. The width value of 
the Rt ovary separates the fertile from the infertile 
significantly (p < 0.05) in average; where the ovarian 
width for the infertile were bigger than the fertile one 
(Figure 4-a), as well as the Lt ovary length, which 
shows that the ovary length of the infertile female were 
bigger than that of the fertile one (Figure 4-b). In case of 
hormones; FSH also discriminates between the fertile 
and infertile; where the values of this hormones were 
lower among infertile female compared with fertile one 
(Figure 5-a), while LH (Fig. 5-b) showed wide 
variability for the fertile ones as well as low value in 
average than the infertile one. Still, in coordination with 
the other variable, it helps in the discrimination 
between the two status. Based on integrating the results 
of both ultrasound and laboratory exams using SLDA, 
the differentiation/classification between fertile and 
infertile female could be successfully derived by the 




The vote will be to the higher values; i.e. the four values 
substituted in the two equations simultaneously and 
the bigger output defines the despondence's fertility. 
Table 1. Shows the Stepwise Linear Discriminant 
Analysis (SLDA) to classify women as fertile or infertile 





FSH 0.190 0.084 
LH -0.042 0.040 
Rt ovary width 0.597 0.669 
Lt ovary Length 0.378 0.465 
(Constant) -15.072 -19.499 








Figure 4: Error bar plot shows the discriminant power of (a) 
Rt ovary width and (b) Lt ovary length in discrimination 






















Figure 5: Error bar plot show the discriminant power of (a) 
FSH and (b) LH discrimination between the fertile and non-





The differentiation between fertile and infertile 
females is still a challenging issue, but this study makes 
it possible to predict the infertile ladies based on the 
ovarian morphology and quantify the 
fertility/infertility in percent depending on an equation 
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